After Failed Parkinson’s Trial, Sanofi Pauses Drug Development Programs
Source: Pixabay

After Failed Parkinson’s Trial, Sanofi Pauses Drug Development Programs

During clinical trials, researchers work to advance clinical knowledge, build an understanding of certain diseases or conditions, and learn more about a new drug, surgical device, or behavioral modification technology. However,…

Continue Reading After Failed Parkinson’s Trial, Sanofi Pauses Drug Development Programs
Could a Levodopa Enriched Tomato Be the Fix for Parkinson’s? 
https://pixabay.com/photos/tomato-food-eating-red-vegetable-1205699/

Could a Levodopa Enriched Tomato Be the Fix for Parkinson’s? 

If you've ever heard the term "levodopa" be discussed, it was probably in regards to Parkinson's disease. Currently, levodopa (L-DOPA) is the most commonly prescribed therapy for patients with Parkinson's.…

Continue Reading Could a Levodopa Enriched Tomato Be the Fix for Parkinson’s? 

Why The FDA Cautions Rare Neurological Disease Patients About Dental Amalgams

In a press release from the FDA; the FDA has new recommendations for a common mercury-based filling, dental amalgams. While the mercury in the tooth treatment isn't significant enough to…

Continue Reading Why The FDA Cautions Rare Neurological Disease Patients About Dental Amalgams
Baylor College Team Discovers the Origin of Alpha-1 Antitrypsin Deficiency in Infants
source: pixabay.com

Baylor College Team Discovers the Origin of Alpha-1 Antitrypsin Deficiency in Infants

  A recent article in Science News highlighted a discovery by Richard Seifes, M.D. of Baylor College of Medicine.  Dr. Seifes has discovered the origin of a liver disease that…

Continue Reading Baylor College Team Discovers the Origin of Alpha-1 Antitrypsin Deficiency in Infants

Could TKIs Be Effective for Patients with Alzheimer’s, Parkinson’s, and Dementia?

What sort of treatments are available for patients with dementia and other neurodegenerative conditions? Are these treatments safe and effective? While these questions vary in answers, researchers are currently exploring…

Continue Reading Could TKIs Be Effective for Patients with Alzheimer’s, Parkinson’s, and Dementia?

New Test Developed to Better Assess the Efficacy of Spinocerebellar Ataxia Type 3 Therapies

Researchers at the Mayo Clinic have collaborated with the international community to develop a potential way to test for spinocerebellar ataxia type 3 (SCA3), also called Machado-Joseph Disease. Additionally, they…

Continue Reading New Test Developed to Better Assess the Efficacy of Spinocerebellar Ataxia Type 3 Therapies
Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
source: pixabay.com

Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases

  According to a recent article in Business Wire, it is estimated that five million people in the United States over the age of sixty-five are coping with Alzheimer’s at…

Continue Reading Patients Receive First Dosing of Experimental Drug Targeting Neurodegenerative Diseases
Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete
source: pixabay.com

Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete

According to a story from BioSpace, the biopharmaceutical company Clene Nanomedicine, Inc., has recently announced that it has completed the process of enrollment patient participants in its upcoming phase 2…

Continue Reading Enrollment for Phase 2 Amyotrophic Lateral Sclerosis Trial is Complete